PeptX supplies Tirzepatide (LY3298176, the research reference for Mounjaro), the GLP-1 and GIP dual incretin receptor agonist developed by Eli Lilly, to UK research laboratories and group-buy collectives. manufacturer-stated 99%+ purity, tracked UK delivery, GBP pricing settled at the live mid-market FX rate.
View the full PeptX research peptide catalogue, or browse Retatrutide, Tirzepatide, Semaglutide, BPC-157, TB-500 and GHK-Cu.